Press release
Cancer Anorexia Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Medication, Clinical Trials, Therapies, and Companies by DelveInsight
Cancer Anorexia Treatment Market
(Albany, USA) DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The Cancer Anorexia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cancer Anorexia market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Cancer Anorexia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cancer Anorexia market.
To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Forecast [https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the key facts of the Cancer Anorexia Market Report:
* The Cancer Anorexia market size was valued approximately ~USD 310 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
* - In November 2024, Endevica Bio's investigational peptide, designed to counteract cachexia-related weight loss, demonstrated significant benefits in preclinical rodent models of cancer chemotherapy. According to a study published in the Journal of Clinical Investigation, the peptide, TCMCB07 (B07), improved appetite while maintaining lean and fat mass. These findings highlight the promising potential of TCMCB07 to address chemotherapy-induced anorexia and weight loss, offering hope to millions of patients globally.
* In 2023, the US reported around 277,200 cases of cancer anorexia, with an expected increase throughout the forecast period.
* In the EU4 and the UK, Germany had the highest number of cancer anorexia incident cases, whereas Spain had the fewest.
* Lung cancer represents the highest number of anorexia incident cases among all cancer types, with approximately 150,300 cases in the US.
* The anticipated launch of promising therapies ART27.13 (Artelo Biosciences) and NGM120 (NGM Biopharmaceuticals) is expected to drive market growth in the coming years, supported by a rise in the incident population of cancer anorexia.
* Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others
* Key Cancer Anorexia Therapies: ADLUMIZ/EDOLMIZU, Adlumiz, ART27.13, NGM120, and others
* The Cancer Anorexia epidemiology based on gender analyzed that Cancer Anorexia occurs in both men and women
* The Cancer Anorexia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cancer Anorexia pipeline products will significantly revolutionize the Cancer Anorexia market dynamics.
Cancer Anorexia Overview
Cancer anorexia is a common and distressing condition characterized by a significant loss of appetite in cancer patients. It is often associated with cancer cachexia, a multifactorial syndrome that leads to severe weight loss, muscle wasting, and metabolic changes. Anorexia in cancer patients can result from multiple factors, including tumor-induced inflammation, altered metabolism, treatment side effects (such as chemotherapy and radiation), psychological distress, and gastrointestinal symptoms like nausea and early satiety.
Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-) and interleukins, play a key role in disrupting appetite regulation by affecting the hypothalamus. Additionally, cancer treatments may cause taste alterations, mucositis, and gastrointestinal discomfort, further contributing to reduced food intake.
The consequences of cancer anorexia include malnutrition, reduced quality of life, impaired immune function, and poor treatment tolerance. Management strategies focus on nutritional interventions, appetite stimulants (such as megestrol acetate), corticosteroids, and supportive therapies like counseling and palliative care. Emerging treatments, including ghrelin analogs and anti-inflammatory agents, are being explored to combat cancer anorexia.
A multidisciplinary approach involving oncologists, dietitians, and palliative care specialists is essential to address this condition and improve the overall well-being of cancer patients.
Get a Free sample for the Cancer Anorexia Market Report : https://www.delveinsight.com/report-store/cancer-anorexia-market [https://www.delveinsight.com/report-store/cancer-anorexia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Cancer Anorexia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cancer Anorexia Epidemiology Segmentation:
The Cancer Anorexia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
* Total Prevalence of Cancer Anorexia
* Prevalent Cases of Cancer Anorexia by severity
* Gender-specific Prevalence of Cancer Anorexia
* Diagnosed Cases of Episodic and Chronic Cancer Anorexia
Download the report to understand which factors are driving Cancer Anorexia epidemiology trends @ Cancer Anorexia Epidemiology Forecast [https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Cancer Anorexia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Anorexia market or expected to get launched during the study period. The analysis covers Cancer Anorexia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cancer Anorexia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Cancer Anorexia Therapies and Key Companies
* ADLUMIZ/EDOLMIZU: Helsinn Healthcare
* Adlumiz: Helsinn Healthcare
* ART27.13: Artelo Biosciences
* NGM120: NGM Biopharmaceuticals
Discover more about therapies set to grab major Cancer Anorexia market share @ Cancer Anorexia Treatment Market [https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Cancer Anorexia Market Drivers
* An increasing population of cancer patients with anorexia in the 7MM
* Scope of upcoming therapies
* Opportunity for novel treatments
* Presence of effective disease scoring system
Cancer Anorexia Market Barriers
* Disease burden and impact on the quality of life
* Lack of knowledge about the condition
* The high mortality rate in cancer patients due to anorexia
Scope of the Cancer Anorexia Market Report
* Study Period: 2020-2034
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Cancer Anorexia Companies: Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others
* Key Cancer Anorexia Therapies: ADLUMIZ/EDOLMIZU, Adlumiz, ART27.13, NGM120, and others
* Cancer Anorexia Therapeutic Assessment: Cancer Anorexia current marketed and Cancer Anorexia emerging therapies
* Cancer Anorexia Market Dynamics: Cancer Anorexia market drivers and Cancer Anorexia market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Cancer Anorexia Unmet Needs, KOL's views, Analyst's views, Cancer Anorexia Market Access and Reimbursement
To know more about Cancer Anorexia companies working in the treatment market, visit @ Cancer Anorexia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Cancer Anorexia Market Report Introduction
2. Executive Summary for Cancer Anorexia
3. SWOT analysis of Cancer Anorexia
4. Cancer Anorexia Patient Share (%) Overview at a Glance
5. Cancer Anorexia Market Overview at a Glance
6. Cancer Anorexia Disease Background and Overview
7. Cancer Anorexia Epidemiology and Patient Population
8. Country-Specific Patient Population of Cancer Anorexia
9. Cancer Anorexia Current Treatment and Medical Practices
10. Cancer Anorexia Unmet Needs
11. Cancer Anorexia Emerging Therapies
12. Cancer Anorexia Market Outlook
13. Country-Wise Cancer Anorexia Market Analysis (2020-2034)
14. Cancer Anorexia Market Access and Reimbursement of Therapies
15. Cancer Anorexia Market Drivers
16. Cancer Anorexia Market Barriers
17. Cancer Anorexia Appendix
18. Cancer Anorexia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cancer-anorexia-treatment-market-2034-ema-pdma-fda-approvals-prevalence-medication-clinical-trials-therapies-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/regulatory-analysis-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Anorexia Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, Medication, Clinical Trials, Therapies, and Companies by DelveInsight here
News-ID: 3854056 • Views: …
More Releases from ABNewswire
WORLD5 Releases Third Studio Album 3 on Vinyl and CD
Critically Acclaimed International Pop-Rock Band Expands Album Availability.
WORLD5, the internationally recognized pop-rock band, announces the release of their third studio album, 3 , now available in both vinyl and CD formats. Following its successful digital release through Spectra Music Group, the album is now accessible to collectors and music enthusiasts who appreciate physical editions.
Since their formation in 2011, WORLD5 has built a global following with their signature blend of pop,…
Expert Epoxy Solutions of North Carolina, Inc. Expands High-Quality Epoxy Floori …
Expert Epoxy Solutions of North Carolina, Inc. delivers high-quality, durable epoxy flooring for homes and businesses across Wilmington and surrounding areas. With expert craftsmanship and a lifetime warranty, they specialize in transforming garages, patios, and commercial spaces. Now expanding to Leland, Wrightsville, Carolina Beach, Southport, Topsail Beach, and Oak Island, they remain the go-to choice for premium epoxy solutions.
Wilmington, NC - Expert Epoxy Solutions of North Carolina, Inc. [https://expertepoxync.com/], a…
"We Built This for Our Kids" - Two Mothers Launch Australian Racism Register to …
Image: https://www.abnewswire.com/upload/2025/03/dc71a352f468747a481087df1c5f173a.jpg
Perth, Western Australia - Two Perth-based mothers, determined to build a safer and more just future for their children, have launched The Racism Register-Australia's first community-driven, independent racism reporting platform. This platform allows anyone-whether they've experienced or witnessed racism-to report it anonymously. This groundbreaking platform transforms lived experience and witnessed accounts of racism into a growing national record, offering support to those affected and advocating for systemic change.
"As migrant…
Master Affiliate Profit Phase 3 Launch Set for March 25, 2025
Industry-leading affiliate marketing program moves into its third phase with new opportunities for marketers worldwide.
Singapore - March 24, 2025 - The highly anticipated launch of Master Affiliate Profit (MAP) Phase 3 will officially take place on March 25, 2025. Created by respected affiliate marketing educators Melinda & Omar Martin and John Thornhill, MAP Phase 3 introduces an enhanced platform for affiliate marketers seeking practical training, proven strategies, and scalable growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
